Guidance Software, Inc. (NASDAQ: GUID), the World Leader in Digital Investigations™, today announced a leading not-for-profit healthcare organization has purchased a complete suite of EnCase products to gain visibility into the location of sensitive patient information across its network of over 100 locations serving more than 10,000 members. According to a Ponemon Institute study, criminal attacks on healthcare organizations have increased 100 percent since 2010.1 Using EnCase, these organizations can locate and detect misuse of sensitive data wherever it resides, collect evidence for legal proceedings, and quickly and effectively respond to cyberattacks.
The U.S. Department of Health and Human Services estimates that somewhere between 27.8 and 67.7 million people’s medical records have been breached since 2009. The healthcare industry is under attack. Reputations and patients are at risk, as well as compliance with the Health Insurance Portability and Accountability Act (HIPAA) which regulates the protection of the confidentiality and security of healthcare information. EnCase provides a comprehensive approach to data investigation, legal discovery automation, incident response, and sensitive data discovery in a single suite of products to help mitigate legal and security risks for organizations in healthcare and other industries.
The organization first deployed EnCase® Enterprise to meet internal investigations requirements. It then expanded to use of EnCase® eDiscovery to support litigation processes. Most recently, they added EnCase® Cybersecurity for incident response and sensitive data discovery, allowing them to remediate security threats and locate patient information stored on unauthorized devices. To further strengthen their security posture, the company also invested in EnCase® Analytics to look for signs of intrusion, locate malware, and identify user policy violations across the organization’s systems.
“With greater access to healthcare services due to the Patient Protection and Affordable Care Act (PPACA), more and more consumers are entering the system, further burdening the resources of hospitals, physicians and others that deal with very sensitive information,” said Jay Ackerman, Chief Revenue Officer for Guidance Software. “Guidance Software offers a powerful toolkit to address key security and legal risks for industries under continuous scrutiny and threat, like the healthcare sector, benefiting both the organizations and their patients.”
Consistently rated among the top performing health systems in their region, the organization is using the following EnCase products:
- EnCase Enterprise – The leading digital forensic tool for remote investigations. It enables users to discreetly, accurately, and securely access machines anywhere on their networks in order to preview, collect, and examine digital evidence in a forensically sound manner.
- EnCase Analytics – An endpoint-based security analytics solution that exposes signs of intrusion, behavioral anomalies, and advanced threats across the enterprise.
- EnCase Cybersecurity – An incident response product that enables your security team to respond quickly to incoming threat alerts to prioritize, investigate, and remediate incidents using endpoint data for context.
- EnCase eDiscovery – A market-leading and court-accepted solution that automates Electronic Discovery Reference Model (EDRM) workflows for legal and regulatory investigations, accelerates the collection and preservation of ESI, and enables collaborative review and production of evidence.
Guidance Software was named 2013 market share leader by Gartner for Endpoint Detection and Response (EDR) tools in its November 2014 Competitive Landscape Report. Guidance Software has also been named a “leader” in Gartner Inc.’s 2014 Magic Quadrant for e-discovery software, in its fourth annual industry report.
1 2014 Ponemon Institute Benchmark Study on Patient Privacy and Data Security, Page 2
About Guidance Software, Inc.
Guidance Software is recognized worldwide as the industry leader in endpoint investigation solutions for security incident response, e-discovery and forensic analysis. Its EnCase® Enterprise platform, deployed on an estimated 25 million endpoints, is used by more than 70 percent of the Fortune 100, more than 45 percent of the Fortune 500, and numerous government agencies to conduct digital investigations of servers, laptops, desktops and mobile devices. Built on the EnCase Enterprise platform are market-leading cybersecurity, IT help desk, and electronic discovery solutions, EnCase® Cybersecurity, EnCase® Analytics, EnCase® Remote Recovery + and EnCase® eDiscovery. They empower organizations to conduct speedy and thorough security incident response, reveal previously hidden security threats or malicious insider activity, recover lost files, perform sensitive data discovery, and respond to litigation discovery requests. For more information about Guidance Software, visit www.encase.com.
EnCase®, EnScript®, FastBloc®, EnCE®, EnCEP®, Guidance Software™, LinkedReview™, EnPoint™ and Tableau™ are registered trademarks or trademarks owned by Guidance Software in the United States and other jurisdictions and may not be used without prior written permission. All other trademarks and copyrights referenced in this press release are the property of their respective owners.
